CureLab Oncology Granted US Patent for Therapeutic Use of its Lead Product in ALS, Alzheimer’s, Huntington’s, and Parkinson’s Diseases
- Tuesday, July 20, 2021, 5:30
- PR Newswire
- Add a comment
BOSTON, July 20, 2021 /PRNewswire/ — CureLab Oncology, a clinical-stage biotech company, has been granted a US patent for the application of its lead product for the treatment of ALS, Alzheimer’s, Huntington’s, and Parkinson’s disease. These patent applications were already granted in…
About the Author
admin has written 20655 stories on this site.